Trial NCT01104662

View at ClinicalTrials.gov 
Org. Study IDs: 3009-022
Secondary IDs: DAP-RENSE-08-05

Last trial update was posted on 2018-09-05

MeSH Interventions

Cloxacillin Daptomycin Nafcillin Oxacillin Penicillins Vancomycin

MeSH Conditions

Bacteremia Communicable Diseases Infections Renal Insufficiency Skin Diseases, Bacterial

Other Conditions

Complicated Skin and Skin Structure Infections Renal Impairment S. Aureus Bacteremia

Stopping Reasons

Cubist has reached an agreement with the FDA that enrollment in the DAP-RENSE-08-05 study can stop.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID